Did you know?

May. 25, 2023, 09:05 PM. In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Hold rating on Verastem ( VSTM – Research Report ), with a price target of $2.00. The ...RBC Capital Markets, LLC. Gregory Renza. Truist. Srikripa Devarakonda. Verastem, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Verastem, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Verastem, Inc. or its management.Rugged smartphones are industrial-grade smartphones with enhanced protective features that allow them to perform in extreme or hazardous environments. If you buy something through ...BOSTON--(BUSINESS WIRE)--Mar. 18, 2021-- Verastem, Inc. (Nasdaq: VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today reported financial results for the three months and full year ending December 31, 2020, and highlighted its key corporate objectives for ...On January 24, 2023, Verastem Oncology announced that it had entered into a definitive agreement to sell up to approximately 2.1 million shares of Preferred Stock to affiliates of BVF Partners L.P. in a private placement to raise aggregate gross proceeds of up to approximately $60 million in two tranches, before deducting fees to the placement agent …Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote …On January 24, 2023, Verastem Oncology announced that it had entered into a definitive agreement to sell up to approximately 2.1 million shares of Preferred Stock to affiliates of BVF Partners L.P. in a private placement to raise aggregate gross proceeds of up to approximately $60 million in two tranches, before deducting fees to the placement agent …Watertown, Mass. (February 7, 2024) – Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, today announced that management will participate in several upcoming investor conferences: Oppenheimer 34th Annual …The latest Verastem stock prices, stock quotes, news, and VSTM history to help you invest and trade smarter. Menu icon A vertical stack of three evenly spaced horizontal lines.Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs. March 11, 2024View Verastem, Inc VSTM investment & stock information. Get the latest Verastem, Inc VSTM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Popular. Track Vroom Inc. (VRM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.By: Brian Stuglik, CEO, Verastem Oncology. Over the past year, those of us working in pharmaceutical oncology R&D have watched with awe as industry colleagues worked together to speed vaccinations for COVID-19 from the lab to patients’ arms in record time. Breakthroughs in cancer research, typically don’t happen that quickly.Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Verastem Trading Up 2.5 %. Shares of NASDAQ:VSTM opened at $12.18 on Friday. The business’s 50-day moving average is $11.25 and its 200 day moving average is $10.20. Verastem has a 1 year low of ...Track Iovance Biotherapeutics Inc (IOVA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line patients treated with novel combo therapy in the initial cohort of its …Mr Paterson joined Verastem Oncology in 2011 and was its President and Chief Operating Officer prior to becoming President and Chief Executive Officer in 2023. He has more than 30 years of experience at healthcare and biotechnology companies, including leadership roles as Chief Business Officer (CBO), Chief Operating Officer (COO) and Chief ...Verastem Oncology is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accurary of the information contained in the linked sites. We suggest that you always verify the information obtained ...

10.86. +3.43%. Discover historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly format back to when Verastem, Inc. stock was issued.A new lawsuit suggests Melania Trump should have been able to become a multimillionaire in her own right as First Lady. By clicking "TRY IT", I agree to receive newsletters and pro...VSTM Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Verastem, Inc. VSTM stock quote prices, financial information, real-time forecasts, and company news from CNN.Verastem Oncology, Inc. (NASDAQ: VSTM), is a biopharmaceutical company headquartered in Needham, MA. The focus of our research is developing a portfolio of novel small molecule drugs that inhibit critical RAS signaling pathways that promote cancer cell survival and tumor growth. To learn more about our research program, as well as the details ...

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote ...Verastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019-)Track VistaGen Therapeutics Inc (VTGN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Track Microsoft Corp (MSFT) Stock Price, Quote, latest community m. Possible cause: VSTM on StockTwits; VSTM on Twitter; Verastem, Inc., a biopharmaceutical company, focu.